Oklahoma 2023 Regular Session

Oklahoma Senate Bill SB765

Introduced
2/6/23  
Refer
2/7/23  

Caption

Practice of pharmacy; requiring wholesale distributors to provide for return of certain outdated prescription drugs; requiring prompt full credit to purchaser. Effective date.

Impact

The implementation of SB 765 is likely to enhance the management of expired medications statewide, offering a structured process for drug returns. This could lead to better compliance with state laws governing pharmaceuticals, thus improving health and safety standards related to drug handling. Establishing clear guidelines for credit on returned medications may encourage pharmacies to manage their inventories more responsibly, reducing the risks associated with outdated drugs remaining on shelves.

Summary

Senate Bill 765, introduced by Senator Standridge, aims to regulate the practice of pharmacy specifically concerning the return of outdated prescription drugs by wholesale distributors. The bill requires these distributors to establish written policies for returning expired drugs, ensuring that they are either returned to manufacturers or handled through designated reverse drug distributors. Furthermore, it stipulates that wholesale distributors must provide full credit for returned drugs within a specified timeframe, reinforcing the responsibility to maintain adequate procedures on this front.

Sentiment

Generally, the sentiment surrounding SB 765 appears to be supportive, especially among stakeholders in the pharmacy sector who recognize the need for clearer regulations on expired medications. The bill has garnered bipartisan support, as indicated by its smooth passage through the Health and Human Services Committee with unanimous voting in favor. The emphasis on consumer safety and accountability reflects a collaborative approach to pharmaceutical regulation.

Contention

While the bill is largely supported, potential points of contention may arise from the administrative burden it places on wholesale distributors to establish comprehensive return policies and maintain documentation for audits. Questions may be raised regarding the practicality of enforcing new protocols and the financial implications for smaller distributors. Additionally, exemptions, such as those related to influenza vaccines, may lead to debates about equitable treatment across various drug classes.

Companion Bills

No companion bills found.

Previously Filed As

OK SB426

Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.

OK SB426

Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.

OK SB741

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

OK SB741

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

OK SB2007

Pharmacy Benefit Managers; requiring PBM to remit certain fees. Effective date.

OK LB10

Change requirements relating to wholesale drug distributors and dispensing of certain prescription drugs

OK SB29

Health care; requiring licensed practitioners to offer pharmacogenomic test prior to prescription of psychotropic drugs. Effective date.

OK SB29

Health care; requiring licensed practitioners to offer pharmacogenomic test prior to prescription of psychotropic drugs. Effective date.

OK SB176

Health benefit plans; requiring coverage for certain prescription. Effective date.

OK SB176

Health benefit plans; requiring coverage for certain prescription. Effective date.

Similar Bills

FL S0262

Storage and Disposal of Prescription Drugs and Sharps

IL SB3896

WHOLESALE DRUG DISTRIBUTORS

IL HB5427

WHOLESALE DRUG DISTRIBUTORS

TX SB1484

Relating to the marketing and sale of catfish and similar fish by food service establishments, food service suppliers, wholesalers, distributors, and wholesale distributors; providing administrative and civil penalties.

FL H0283

Storage and Disposal of Prescription Drugs and Sharps

FL HB283

Storage and Disposal of Prescription Drugs and Sharps:

NJ A4184

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

KY HB772

AN ACT relating to pharmaceutical manufacturers.